Abstract
The vascularisation of tumours is relatively poor and disordered compared with that normal tissues, leading to inefficient delivery of oxygen and other nutrients to many tu-mour cells. As oxygen diffuses from blood capillaries through the mass of surrounding cells it is depleted by normal cell metabolism. In the pioneering work of Thomlinson and Gray an effective diffusion distance of about 150 µrn was calculated (Thomlinson and Gray 1955) which closely matched the radii of viable tumour cords. Beyond this distance lie radioresistant hypoxic tumour cells at the boundary between viable and necrotic cells. Transient changes in the perfusion of individual blood vessels may further reduce oxygen transport and change the oxygenation status of some cells near to blood vessels over rela-tively short time scales (e.g. Chaplin et al. 1986). Moderate levels of radiobiological hy-poxia are also known to exist in some normal tissues e.g. murine skin (Stewart et al 1982) and liver (Arteel et al. 1995).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aboagye, E.O., Lewis, A.D., Johnson, A., Workman, P., Tracy, M. and Huxham, I.M., 1995. The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: reductive metabolism and semi-quantitative localisation in hu-man ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysis. Br. J. Cancer, 72,312–318.
Arteel, G.E., Thurman, R.G., Yates, J.M., Raleigh, J.A., 1995. Evidence that hypoxia markers detect oxygen gradi-ents in liver: pimonidazole and retrograde perfusion of rat liver. Br J. Cancer, 72, 889–895.
Biskupiak, J.E., Grierson, J.R., Rasey, J.E., Martin, G.V. and Krohn, K.A., 1991. Synthesis of an (iodovinyl)mi-sonidazole derivative for hypoxia imaging. J. Med. Chem., 34, 2165–2168.
Chaplin, DJ., Durand, R.E. and Olive, P.L., 1986. Acute hypoxia in tumours: implications for modifiers of radia-tion effects. Int. J. Radiat. Oncol. Biol. Phys., 12, 1279–1282.
Chapman, J.D., Franko, A.J. and Sharplin, J., 1981. A marker for hypoxic cells in tumours with potential clinical applicability. Br. J. Cancer, 43, 546–550.
Cline, J.M., Thrall, D.E., Rosner, G.L. and Raleigh, J.A., 1994. Distribution of the hypoxia marker CC1-103F in canine tumours. Int. J. Radiat. Oncol. Biol. Phys., 28, 921–933.
Evans, S.M., Jenkins, W.T., Joiner, B., Lord, E.M. and Koch, C.J., 1996. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. Cancer Res., 56, 405–411.
Franko, A.J. and Chapman, J.D., 1982. Binding of 14C-misonidazole to hypoxic cells in V79 spheroids. Br J. Cancer, 45, 694–699.
Franko, A.J., Koch, C.J., Garrecht, B.M., Sharplin, J. and Hughes, D., 1987. Oxygen dependence of binding of mi-sonidazole to rodent and human tumors in vitro. Cancer Res., 47, 5367–5376.
Hirst, D.G. and Denekamp, J., 1979. Tumour cell proliferation in relation to the vasculature. Cell Tissue Kinet., 12, 31–42.
Hodgkiss, R.J., Jones, G., Long, A., Parrick, J., Smith, K.A., Stratford, M.R.L., and Wilson, G.D., 1991. Flow cy-tometric evaluation of hypoxic cells in solid experimental tumors using fluorescence immunodetection. Br. J. Cancer,63,119–125.
Hodgkiss, R.J. and Wardman, P., 1992. The measurement of hypoxia in tumours. Br J. Radiol., Suppl. 24, 105–110.
Hodgkiss, R.J., Parrick, J., Porssa, M. and Stratford, M.R.L., 1994. Bioreductive markers for hypoxic cells: 2-ni-troimidazoles with biotinylated 1-substituents. J. Med. Chem., 37, 4352–4356.
Hodgkiss, R.J., Stratford, M.R.L., Dennis, M.F. and Hill, S.A., 1995. Pharmacokinetics and binding of the biore-ductive probe for hypoxia, NITP: effect of route of administration. Br J. Cancer, 72, 1462–1468.
Li, S.J., Jin, G.Y. and Moulder, J.E., 1991. Prediction of tumour radiosensitivity by hexafluoromisonidazole reten-tion monitored by [1H]/[19F] magnetic resonance spectroscopy. Cancer Comms., 3, 133–139.
Linder, K.E., Chan, Y.W., Cyr, J.E., Malley, M.F., Nowotnik, D.P. and Nunn, A.D., 1994. TcO(PnA.O-l-(2-ni-troimidazole)) [BMS-181321 ], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterisation, and xanthine oxidase-catalysed reduction. J. Med. Chem., 37, 9–17.
A. Long, J. Parrick and R.J. Hodgkiss, 1991. An efficient procedure for the 1-alkylation of 2-nitroimidazoles and the synthesis of a probe for hypoxia in solid tumours. Synthesis, 9, 709–713.
Mannan, R.H., Mercer, J.R., Wiebe, L.I., Kumar, P., Somayaji, V.V. and Chapman, J.D., 1992a. Radioiodinated azomycin pyranoside (IAZP): a novel non-invasive marker for the assessment of tumour hypoxia. J. Nucl. Biol. Med., 36, 60–67.
Mannan, R.H., Mercer, J.R., Wiebe, L.I., Somayaji, V.V. and Chapman, J.D., 1992b. Radioiodinated l-(2-fluoro-4-iodo-2,4-dideoxy-beta-L-xylopyranosyl)-2-nitroimidazole: a novel probe for the non-invasive assessment of tumor hypoxia. Radiat. Res., 132, 368–374.
Mason, R.P. and Holtzman J.L., 1975. The role of catalytic Superoxide formation in the O2 inhibition of nitrore-ductase. Biochem. Biophys. Comms. 67, 1267–1274.
Maxwell, R.J., Workman, P. and Griffiths, J.R., 1987. Demonstration of tumour-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy. Int. J. Radiat. Oncol. Biol. Phys., 16, 925–929.
Raleigh, J.A., Franko, A.J., Koch, C.J. and Born, J.L., 1985. Binding of misonidazole to hypoxic cells in mono-layer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label. Br. J. Cancer, 51, 229–235.
Raleigh, J.A., Franko, A.J., Treiber, E.O., Lunt, J.A. and Allen, P.S., 1986. Covalent binding of a fluorinated 2-ni-troimidazole to EMT-6 tumours in BALB/C mice: detection by F-19 nuclear magnetic resonance at 2.35 T. Int. J. Radiat. Oncol. Biol. Phys., 12, 1243–1245.
Raleigh, J.A., Miller, G.G., Franko, A.J., Koch, C.J., Fuciarelli, A.F. and Kelley, D.A., 1987. Fluorescence immu-nohistochemical detection of hypoxic cells in spheroids and tumours. Br. J. Cancer, 56, 395–400.
Rasey, J.S., Koh, W.J., Grierson, J.R., Grunbaum, Z. and Krohn, K.A., 1989. Radiolabelled fluoromisonidazole as an imaging agent for tumour hypoxia. Int. J. Radiat. Oncol. Biol. Phys., 17, 985–991.
Rasey, J.S., Krohn, K.A., Grunbaum, Z., Conroy, P.J., Bauer, K. and Sutherland, R.M., 1985. Further charac-terisation of 4-bromomisonidazole as a potential detector of hypoxic cells. Radiat. Res. 102, 76–85.
Rojas, A., Joiner, M.C., Hodgkiss, R.J. Carl, U., Kjellen E. and Wilson, G.D., 1992. Enhancement of tumor ra-diosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys. Int. J. Radiat. Oncol. Biol. Phys., 23, 361–366
Rumsey, W.L., Patel, B. and Linder, K.E., 1995. Effect of graded hypoxia on retention of technetium-99m-nitro-heterocycle in perfused rat heart. J. Nucl. Med., 36, 632–636.
Stewart, F.A., Denekamp, J. and Randhawa, VS., 1982. Skin sensitisation by misonidazole: a demonstration of uniform mild hypoxia. Br. J. Cancer, 45, 869–877.
Thomlinson and Gray, 1955. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer, 9, 539–549.
Urtasun, R.C., Chapman, J.D., Raleigh, J.A., Franko, A.J. and Koch, C.J., 1986a. Binding of 3H-misonidazole to solid human tumours as a measure of tumour hypoxia. Int. J. Radiat. Oncol. Biol. Phys., 12, 1263–1267.
Urtasun, R.C., Koch, C.J., Franko, A.J., Raleigh, J.A. and Chapman, J.D., 1986b. A novel technique for measuring human tissue pO2 at the cellular level. Br. J.Cancer, 54, 453–57.
Wardman, P. and Clarke, E.D., 1976. Oxygen inhibition of nitroreductase electron transfer from nitro radical-ani-ons to oxygen. Biochem.. Biophys. Res. Com. 69, 942–949.
Webster, L., 1994. Hypoxia and proliferation in murine tumour models. PhD Thesis University of London Faculty of Science.
Webster, L., Hodgkiss, R.J. and Wilson, G.D., 1995. Simultaneous triple staining for hypoxia, proliferation and DNA content in solid murine tumors. Cytome Uy, 21, 344–351.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hodgkiss, R.J., Webster, L., Wilson, G.D. (1997). Measurement of Hypoxia in Vivo Using A 2-Nitromidazole (NITP). In: Harrison, D.K., Delpy, D.T. (eds) Oxygen Transport to Tissue XIX. Advances in Experimental Medicine and Biology, vol 428. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5399-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5399-1_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7465-7
Online ISBN: 978-1-4615-5399-1
eBook Packages: Springer Book Archive